Neuroscience Graduate Program at UCSF
Genetics and Biology of Human Nervous System Disorders
My work has focused on identification and characterization of genes that cause normal variations and disorders of the nervous system. One area of particular interest has been in episodic disorders of muscle, heart, and brain. In many cases, these episodic phenomena result from alterations in electrical signaling of cell membranes in these tissues. Initially, by studying a complex group of clinical phenotypes called the periodic paralyses and non-dystrophic myotonias, we began systematically mapping and cloning genes responsible for these phenotypes. These have turned out to be genes that encode ion channels with specificity for sodium, calcium, chloride, and potassium ions. Once identified, it has been possible for us and others to express wild-type and mutant ion channel genes in heterologous expression systems to characterize functional consequences of mutations in the function of these channels. This approach has been very complimentary to site-directed mutagenesis studies that have been done without attention to any particular human disease. These "experiments of nature" focus our attention on discrete regions of the channels and thus can be very informative for structure-function studies. Ongoing work is focused on looking for epistatic interactions between these and other genes, and modeling of the human diseases in other organisms such as mice. The ability to study mutations in vivo will allow us to ask questions that cannot be approached because of the difficulty in obtaining human tissues.
Recently we have identified a gene that causes a rare disorder called Andersen-Tawil syndrome (ATS). The gene accounting for a majority of the families that we've identified is KCNJ2. This gene encodes an inwardly rectifying potassium channel (Kir2.1). Interestingly, ATS is clinically recognized as a triad of periodic paralysis, cardiac arrhythmias, and developmental features affecting the face and limbs. We have done extensive work in characterizing the physiological consequences of these mutations on Kir2.1 currents and also have identified mutations that affect co-assembly and trafficking of these proteins. We've also generated transgenic mice which will allow us to ask questions regarding the role this inwardly rectifying potassium channel in development of cranio-facial and limb structures.
In addition, we are continuing to search for genes causing other episodic phenomena. In a number of cases (epilepsy, movement disorders) the genes that we've identified are not ion channels and represent new windows into understanding other aspects of these episodic phenomena outside of being primary determinants of membrane excitability.
On another front, we became interested in human circadian rhythm genetics upon identifying and characterizing the first human family with a Mendelian variant in their sleep schedule (in collaboration with the laboratory of Ying-Hui Fu). We've gone on to show that these individuals have a familial form of advanced sleep phase syndrome (FASPS). They are normal and healthy but are extreme morning larks. These individuals have a short circadian period that leads them to wake up earlier each day. They ultimately reach an equilibrium where they're waking up so early and going to sleep early enough that they get a strong light impulse to reset their clock for the next day. We've now collected over fifty families with FASPS and are characterizing candidate circadian rhythm genes for variants that cause this phenotype and studying the biochemistry and cell biology of the genetic variants that we're identifying. Furthermore, families that don't have genetic variants in any of the known or predicted candidate genes will provide opportunities to identify novel genetic contributions to human circadian rhythmicity.
1. Identification of a second Andersen-Tawil syndrome gene
2. Functional characterization of functional consequences of ATS KCNJ2 mutations
3. Characterization of transgenic mice with dominant-negative ATS KCNJ2 mutations
4. Identification of genetic contributions to thyrotoxic hypokalemic periodic paralysis
5. Cloning of a gene for familial adult onset myoclonic epilepsy (FAME)
6. Biochemical characterization and animal modeling of a gene and mutations causing paroxysmal non-kinesigenic dyskenesia
7. Identification of the paroxysmal kinesigenic dyskinesia gene
8. Characterization of a novel mouse epilepsy gene (MGR1) causing sound-induced seizure susceptibility
9. Biochemical characterization of novel human circadian rhythm genes and variants
10. Animal modeling of human circadian rhythm gene variants
Jeff Cheung, Laboratory Assistant
William Hallows, Postdoctoral Fellow
Mary Heng, Postdoctoral Fellow
Shen-Yi Bruce Howng, Postdoctoral Fellow
Angela Huang, Postdoctoral Fellow
Yong Huang, Postdoctoral Fellow
Krista Kaasik, Postdoctoral Fellow
Lorna Kategaya, Postdoctoral Fellow
Mary Lange, Administrative Personnel
Hsien-Yang Lee, Postdoctoral Fellow
Shu-Ting Ling, Postdoctoral Fellow
Emily Quinn, Clinical Coordinator
Jonathan Russell, Graduate Student
Daesung Shin, Postdoctoral Fellow
Jenise Wong, Clinical Fellow
Linda Zhang, Laboratory Assistant
Luoying Zhang, Postdoctoral Fellow
Ying Zhang, Laboratory Assistant
Jones CR, Campbell SS, Zone SE, Cooper F, DeSano A, Murphy PJ, Jones B, Czajkowski L, Ptáček LJ. Familial advanced sleep-phase syndrome: a short period circadian rhythm variant in humans. Nat Med. 1999;5:1062-1065.
Coffeen CM, McKenna CE, Koeppen AH, Plaster NM, Maragakis N, Mihalopoulos J, Schwankhaus JD, Flanigan KM, Gregg RG, Ptáček LJ, Fu YH. Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31. Hum Mol Genet. 2000; 9:787-793.
Abbott GW, Butler MH, Bendahhou S, Dalakas M, Ptáček LJ, Goldstein L. Mirp2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell, 2001; 104:217-231.
Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptáček LJ, Fu Y-H. An hPer2 Phosphorylation Site Mutation in Familial Advanced Sleep-Phase Syndrome. Science, 2001;291:1040-1043.
Plaster, NM, Tawil R, Tristani-Firouze M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL,
Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony S, Wolfe G, Fu Y-H, Ptáček LJ. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s Syndrome. Cell, 2001, 105:511-519.
Skradski S, Clark A, Jiang H, White S, Fu Y‑H, Ptáček LJ. A novel gene causing a Mendelian audiogenic mouse epilepsy. Neuron, 2001, 31:537-544.
Bendahhou S, Cummins T, Griggs RC, Waxman SG, Fu Y-H, Ptáček LJ. Sodium channel inactivation defects associated with acetazolamide-exacerbated hypokalemic periodic paralysis. Ann Neurol. 2001, 50:417-420.
Matilla A, Gorbea C, Einum DD, Townsend J, Michalik A, van Broeckhoven C, Jensen CC, Murphy KJ, Ptáček LJ, Fu YH. Association of ataxin-7 with the proteasome subunit S4 of the 10S regulatory complex. Hum Mol Genet. 2001, 10:2821-2831.
Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, Cobo AM, Poza JJ, Behr E, Wagstaff J, Szepetowski P, Pereira S, Mozaffar T, Escolar DM, Fu H-Y, Ptáček LJ. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology, 2003 Jun 10;60(11):1811-6.
Bendahou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu Y-H, Ptáček LJ. Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. J Biol Chem. Dec. 19, 2003 ;278(51):51779-85.
Klein B, Fu Y-H, Ptáček LJ, White SH. cFos immunohistochemical mapping of the audiogenic seizure network and tonotopic neuronal hyperexcitability in the inferior colliculus of the frings mouse. Epilepsy Research, 2004 Nov;62(1):13-25.
Lee H-Y, Xu Y, Huang Y, Ahn A, Bruno M, Abramowicz M, Pandolfo M, Auburger G, Averyanov Y, Kwieciński H, Servidei S, Grimes D, Lang T, Nielsen J, Fu Y-H, Ptáček LJ. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet. 2004, Vol. 13(24);3161-3170.
Xu Y, Padiath Q, Shapiro R, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptáček LJ, Fu Y-H. Functional consequences of a CK1δ mutation causing familial advanced sleep phase syndrome. Nature, 2005: Vol. 434:640-644.
Louis Ptacek, M.D.
UCSF Mission Bay, Box 2922
Fu and Ptacek Laboratories
1550 4th Street, room 548F
San Francisco, CA 94143